Total Payments
$6,366
2024 Payments
$777.72
Companies
32
Transactions
289
Medicare Patients
6,475
Medicare Billing
$550,454
Payment Breakdown by Category
Food & Beverage$6,366 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,366 | 289 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,323 | 46 | $0 (2024) |
| Novo Nordisk Inc | $698.35 | 48 | $0 (2024) |
| Lilly USA, LLC | $588.01 | 36 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $564.63 | 22 | $0 (2019) |
| Amgen Inc. | $407.29 | 7 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $394.63 | 26 | $0 (2024) |
| Allergan Inc. | $346.82 | 11 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $333.28 | 21 | $0 (2023) |
| PFIZER INC. | $272.99 | 16 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $211.55 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $777.72 | 40 | Lilly USA, LLC ($265.54) |
| 2023 | $885.15 | 44 | GlaxoSmithKline, LLC. ($306.05) |
| 2022 | $490.66 | 29 | GlaxoSmithKline, LLC. ($130.03) |
| 2021 | $658.79 | 31 | Amgen Inc. ($125.76) |
| 2020 | $556.23 | 24 | GlaxoSmithKline, LLC. ($177.24) |
| 2019 | $1,075 | 33 | Sunovion Pharmaceuticals Inc. ($315.81) |
| 2018 | $953.63 | 40 | Sunovion Pharmaceuticals Inc. ($248.82) |
| 2017 | $968.56 | 48 | Allergan Inc. ($257.91) |
All Payment Transactions
289 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Neurology | ||||||
| 12/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: Cardiology | ||||||
| 11/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Cardio-renal | ||||||
| 11/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $2.84 | General |
| Category: Cardio-renal | ||||||
| 11/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: RESPIRATORY | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $30.88 | General |
| Category: Cardio-renal | ||||||
| 10/03/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Neurology | ||||||
| 09/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Obesity | ||||||
| 09/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: Cardio-renal | ||||||
| 08/14/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Pain Management | ||||||
| 08/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Diabetes | ||||||
| 08/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Oncology | ||||||
| 08/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: RESPIRATORY | ||||||
| 07/30/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Diabetes | ||||||
| 07/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Diabetes | ||||||
| 07/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $9.96 | General |
| Category: Cardio-renal | ||||||
| 07/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Diabetes | ||||||
| 07/11/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: Diabetes | ||||||
| 06/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Diabetes | ||||||
| 06/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 1,642 | 2,097 | $316,268 | $150,012 |
| 2022 | 27 | 1,517 | 1,833 | $264,101 | $128,144 |
| 2021 | 28 | 1,517 | 1,865 | $264,309 | $134,629 |
| 2020 | 35 | 1,799 | 2,277 | $287,750 | $137,668 |
Total Patients
6,475
Total Services
8,072
Medicare Billing
$550,454
Procedure Codes
122
All Medicare Procedures & Services
122 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 127 | 283 | $65,090 | $25,612 | 39.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 113 | 113 | $19,775 | $14,091 | 71.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 84 | 85 | $28,900 | $10,361 | 35.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 21 | 103 | $14,420 | $9,609 | 66.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 68 | 68 | $25,500 | $9,580 | 37.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 116 | 117 | $13,455 | $9,067 | 67.4% |
| 93976 | Ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2023 | 82 | 82 | $24,600 | $8,825 | 35.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 64 | 65 | $15,710 | $8,312 | 52.9% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 85 | 85 | $17,000 | $7,517 | 44.2% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 85 | 85 | $16,575 | $7,018 | 42.3% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 86 | 86 | $15,050 | $6,761 | 44.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 43 | $10,105 | $5,681 | 56.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 65 | $5,525 | $4,031 | 73.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 16 | $5,360 | $3,400 | 63.4% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 26 | 26 | $3,570 | $3,281 | 91.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 26 | 50 | $5,600 | $3,149 | 56.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 41 | 41 | $3,280 | $2,949 | 89.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 59 | 59 | $5,900 | $1,578 | 26.8% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 35 | 35 | $1,820 | $1,371 | 75.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 26 | 27 | $4,455 | $1,336 | 30.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 43 | 43 | $1,330 | $1,264 | 95.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 18 | $2,430 | $1,253 | 51.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 45 | 71 | $2,130 | $675.92 | 31.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 12 | 14 | $1,680 | $639.63 | 38.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 59 | 60 | $2,400 | $587.77 | 24.5% |
About Dr. Abdullah Raffee, MD
Dr. Abdullah Raffee, MD is a Internal Medicine healthcare provider based in Flint, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1508850736.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abdullah Raffee, MD has received a total of $6,366 in payments from pharmaceutical and medical device companies, with $777.72 received in 2024. These payments were reported across 289 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($6,366).
As a Medicare-enrolled provider, Raffee has provided services to 6,475 Medicare beneficiaries, totaling 8,072 services with total Medicare billing of $550,454. Data is available for 4 years (2020–2023), covering 122 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Geriatric Medicine
- Location Flint, MI
- Active Since 09/02/2005
- Last Updated 08/15/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1508850736
Products in Payments
- TRELEGY ELLIPTA (Drug) $634.44
- LONHALA MAGNAIR (Drug) $465.67
- Kerendia (Drug) $394.63
- FARXIGA (Drug) $322.13
- MOUNJARO (Drug) $315.97
- AREXVY (Drug) $277.79
- Repatha (Biological) $226.68
- VIBERZI (Drug) $208.86
- SHINGRIX (Biological) $184.93
- ENTRESTO (Drug) $154.98
- Aimovig (Biological) $148.17
- Ozempic (Drug) $137.02
- Victoza (Drug) $133.61
- VRAYLAR (Drug) $133.42
- JARDIANCE (Drug) $133.03
- Tresiba (Drug) $130.74
- Saxenda (Drug) $117.27
- TRULICITY (Drug) $113.16
- MYRBETRIQ (Drug) $109.83
- BEXSERO (Biological) $109.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Flint
Henry Mendoza, M.d, M.D
Internal Medicine — Payments: $65,197
Internal Medicine $65,197
Dr. Ahmed Arif, Md, MD
Internal Medicine — Payments: $50,691
Internal Medicine $50,691
Dr. Ryan Malek, D.o, D.O
Internal Medicine — Payments: $17,649
Internal Medicine $17,649
Dr. Kazem Hak, M.d, M.D
Internal Medicine — Payments: $16,743
Internal Medicine $16,743
Kamal Kassem, Md, MD
Internal Medicine — Payments: $15,984
Internal Medicine $15,984
Dr. Miguel Perez-Pascual, M.d, M.D
Internal Medicine — Payments: $14,323
Internal Medicine $14,323